Spero Therapeutics is trading 5.1% down at $1.10 today, extending a series of sharp declines observed over the past week.
- The downward move appears driven by continued negative momentum and broader risk-off sentiment within the biotechnology sector.
- There are no fresh company-specific catalysts or major news headlines reported today to account for the price action.